Lung and thoracic.

7 Phase 1 studies recruiting right now, most recently updated first.

Lung and thoracic7 studies

MesotheliomaNCT06885697

TNhYP218 CAR T Cells

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

National Cancer Institute (NCI)Open the brief

Malignant Pleural EffusionNCT07192900

Locally manufactured adoptive cellular therapy (ACT) product

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

David Bartlett, MDOpen the brief

NSCLC Stage IVNCT05950139

Peptide vaccine

Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOpen the brief

Relapsed/Refractory Small Cell Lung CancerNCT07249879

GC511B CAR-T Cell

This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer

Cancer Institute and Hospital, Chinese Academy of Medical SciencesOpen the brief

Malignant Pleural EffusionNCT07443020

Locally manufactured adoptive cellular therapy (ACT) product

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Open the brief

Non Small Cell Lung CancerNCT05681780Papers

Tumor-infiltrating Lymphocytes (TIL)

CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

H. Lee Moffitt Cancer Center and Research InstituteOpen the brief

Non-small Cell Lung CancerNCT06579196Papers

Trabedersen

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

University of NebraskaOpen the brief